Company Ticker News

Should Biogen Worry About a Congressional Investigation Into Its Alzheimer’s Disease Drug?

Should Biogen Worry About a Congressional Investigation Into Its Alzheimer's Disease Drug?


ylliX - Online Advertising Network

The company faces hard questions from a House committee about the pricing of Alzheimer’s disease drug Aduhelm.

...read full article on The Motley Fool